REG - Tate & Lyle PLC - Directorate Change

Tate & LyleAnnouncement

07/10/2020 07:00

RNS Number : 2919B
  
Tate & Lyle PLC
  
07 October 2020
  
 

 
 
Tate & Lyle PLC - 7 October 2020
 
Directorate Change
 
Tate & Lyle PLC (Tate & Lyle) announces that Imran Nawaz, Chief Financial Officer, has decided to leave the Company to take up the position of Chief Financial Officer of Tesco plc.  Mr Nawaz will remain with Tate & Lyle until April 2021 to close out the current financial year and support an orderly transition.
 
The Board has begun a process to appoint a successor to Mr Nawaz and a further announcement will be made in due course.  
 
Nick Hampton, Chief Executive said: "Imran has been an outstanding finance leader and has played an instrumental role in building the financial discipline to enable us to deliver on our strategy.  I want to thank Imran for his personal support and dedication to the Company over the last two years and wish him every success in the next stage of his career."
 
Gerry Murphy, Chairman, said: "Imran has been a highly valued member of the management team and on behalf of the Board I would like to thank him for his significant contribution to Tate & Lyle and wish him every success in the future."
 
 
For more information contact Tate & Lyle PLC:
Christopher Marsh, VP, Investor Relations
Tel: Mobile: +44 (0) 7796 192 688
 
Nick Hasell and Alex le May, FTI Consulting (Media)
Tel: 0203 727 1340
 
About Tate & Lyle:
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.
 
Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.
 
Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.
 
Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.
 
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle revenue totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAFSAFMMESSESS